Sanofi €3.9 billion acquisition of Ablynx

29/1/2018

Private acquisition

Value:

€ 3.9 billion

Dollar value:

$ 4.322 billion

Status:

Announced

Date:

29/1/2018

Overview:

French pharmaceutical company Sanofi to acquire rival Ablynx for €3.9 billion.

Prin Shasiharan - Researcher

Jurisdictions:

United States
Belgium
France

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

Eubelius

Party: Ablynx (Target)

Lawyers: Lars Van Bever, Matthias Wauters

Goodwin Procter

Party: Ablynx (Target)

Lawyers: Blake Liggio, Blake Liggio, James Matarese, John Mutkoski

Linklaters

Party: Ablynx (Target)

Lawyer: Arnaud Coibion

NautaDutilh

Party: Sanofi SA (Acquirer)

Lawyers: Dirk Van Gerven, Elke Janssens (left the firm), Philippe Remels

Weil Gotshal & Manges

Party: Sanofi SA (Acquirer)

Related deals